Three Former FDA Investigators Revealed Some of Their Secret Inspection Techniques

Three Former FDA Investigators Revealed Some of Their Secret Inspection Techniques

Written by a former FDA Investigator with 14 years of federal service and 13 years as a pharmaceutical quality executive, who sat down with three retired colleagues, combined 40-plus years in the field, and asked them to describe the methods they actually used. Not the policy manual. Not the official procedure. The techniques passed down through experience that consistently produced findings.

This is not general inspection advice. It's a direct account of five specific, field-developed techniques experienced Investigators use to find what facilities believe is hidden, and what your site needs to do about each one before your next inspection:

• Reading the room before reading a single record: the exact behavioral signals (who greets them, who disappears, coordinated hesitation among staff) that shape an Investigator's opinion before the first document request
• Stacking your history against itself: how Investigators cross-reference prior EIRs, 483 responses, APRs, complaint data, and even competitor Warning Letters to catch commitments that were never actually fulfilled
• Following the trail of signatures: the specific data integrity patterns, same-day sign-off clusters, effectiveness checks approved before implementation could realistically be complete, that turn a records review into a falsification finding
• Triangulating complaints against your quality system: how Investigators compare your internal complaint log against public adverse event data before they ever ask to see your records, and what a gap between the two means
• Observing what staff reach for first: the pure behavioral intelligence method that requires no questions at all, just watching how confidently (or not) your team retrieves what's asked for

Each technique includes a direct-quote account from the Investigators who used it, a clear escalation signal explaining what it turns into on paper, and a specific preparation action your site can run before FDA arrives.

If your inspection readiness program is built around documents and SOPs alone, this covers the other side of what Investigators are actually trained to find.

Confidential intelligence for subscribers. Not for redistribution. For informational purposes only and does not constitute legal advice.